Tag archive for ‘China’
By businessnewstoday On Tuesday, February 23rd, 2021

Regor Therapeutics raises $90m for CARD platform in Series B funding round

(adsbygoogle = window.adsbygoogle || []).push({}); Regor Therapeutics has raised $90 million in a Series B financing round towards the discovery and development of discovery of drugs for cancer, More...

By businessnewstoday On Friday, February 12th, 2021

Hindalco subsidiary Novelis to invest $300m to expand Chinese aluminum factory

Novelis, a subsidiary of Hindalco Industries, will invest nearly $300 million to expand its automotive aluminum capabilities and recycling operations at its Zhenjiang aluminum factory in China. In this connection, More...

By pharmanewsdaily On Sunday, February 7th, 2021

AstraZeneca scores Chinese approval for heart failure therapy Forxiga

AstraZeneca said that Forxiga (dapagliflozin) has secured approval in China for its use in the reduction of the risk of cardiovascular (CV) death and hospitalization for heart failure (hHF) in adults having heart More...

By businessnewstoday On Saturday, February 6th, 2021

Allianz (China) Insurance to take full ownership of Allianz China Life

Allianz (China) Insurance (AZCH) will take full ownership in Allianz China Life Insurance by acquiring the 49% stake which it previously did not own from joint venture partner CITIC Trust. The deal is subject to More...

By pharmanewsdaily On Wednesday, February 3rd, 2021

Thermo Fisher, JW Therapeutics sign CAR-T partnership in China

Thermo Fisher Scientific has signed an agreement with Chinese cell therapy company JW Therapeutics to provide the latter non-exclusive commercial access to its Gibco CTS Dynabeads CD3/CD28. The agreement will facilitate More...

By pharmanewsdaily On Sunday, January 31st, 2021

Amgen gets breakthrough therapy status for sotorasib in China

Amgen said that sotorasib, an investigational KRASG12C inhibitor, has been given breakthrough therapy designation (BTD) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) More...

By Soujanya Ravi On Friday, January 22nd, 2021

ADB grants loan to Jointown Pharmaceutical for expanding pharma distribution network in China

The Asian Development Bank (ADB) has agreed to provide a loan of up to €30 million ($37 million) to Jointown Pharmaceutical Group for expanding pharmaceutical distribution facilities in the China (PRC). The loan More...

By businessnewstoday On Friday, November 27th, 2020

CBAK Energy to supply battery packs to EV manufacturer Kandi Vehicles

CBAK Energy Technology, a lithium-ion battery manufacturer and electric energy solution provider, said that its fully owned subsidiary – Dalian CBAK Energy Technology has signed a supply framework agreement More...

By pharmanewsdaily On Thursday, November 26th, 2020

Antengene gets NMPA nod for eltanexor phase 1/2 clinical trial in myelodysplastic syndrome

Antengene has been given approval from China’s National Medical Products Administration (NMPA) for a phase 1/2 clinical trial of ATG-016 (eltanexor) in myelodysplastic syndrome (MDS). The Chinese biopharma company More...

By businessnewstoday On Wednesday, November 25th, 2020

Nestlé to sell Yinlu peanut milk and canned rice porridge businesses in China

Nestlé has signed a deal to divest its Yinlu peanut milk and canned rice porridge businesses in China to Food Wise for an undisclosed price. The deal includes all the operations of Yinlu, which includes five factories More...